Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature
- PMID: 16891608
- DOI: 10.1196/annals.1364.053
Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature
Abstract
Sleep disturbances are hallmark symptoms of posttraumatic stress disorder (PTSD). Where the subjective experience of nightmares and insomnia in PTSD patients is very real indeed and demands treatment, objective research findings on disordered sleep architecture in PTSD are inconclusive and inconsistent. After reviewing the literature an insufficient number of controlled studies are published to formulate evidence-based guidelines. Several studies have methodological limitations, such as small group sizes and heterogenic samples. Large randomized controlled trials (RCTs) need to be conducted in order to further develop adequate therapeutic interventions. Objective parameters for insomnia and nightmares need to be identified for understanding underlying mechanisms of disturbed sleep in PTSD, and for evaluating therapy.
Similar articles
-
[Sleep disturbances in post-traumatic stress disorder. An overview of the literature].Tijdschr Psychiatr. 2007;49(9):629-38. Tijdschr Psychiatr. 2007. PMID: 17853372 Review. Dutch.
-
Prazosin treatment of nightmares related to posttraumatic stress disorder.Ann Pharmacother. 2007 Jun;41(6):1013-7. doi: 10.1345/aph.1H588. Epub 2007 May 15. Ann Pharmacother. 2007. PMID: 17504838 Review.
-
Nightmares, insomnia, and sleep-disordered breathing in fire evacuees seeking treatment for posttraumatic sleep disturbance.J Trauma Stress. 2004 Jun;17(3):257-68. doi: 10.1023/B:JOTS.0000029269.29098.67. J Trauma Stress. 2004. PMID: 15253098
-
Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares.Pharmacopsychiatry. 2001 Jul;34(4):128-31. doi: 10.1055/s-2001-15871. Pharmacopsychiatry. 2001. PMID: 11518472 Clinical Trial.
-
Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.Neuropharmacology. 2012 Feb;62(2):576-85. doi: 10.1016/j.neuropharm.2011.02.029. Epub 2011 Mar 17. Neuropharmacology. 2012. PMID: 21396945 Free PMC article. Review.
Cited by
-
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).CNS Neurosci Ther. 2009 Winter;15(1):84-8. doi: 10.1111/j.1755-5949.2008.00071.x. CNS Neurosci Ther. 2009. PMID: 19228182 Free PMC article.
-
Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory.Neuron. 2011 Jun 9;70(5):830-45. doi: 10.1016/j.neuron.2011.04.023. Neuron. 2011. PMID: 21658578 Free PMC article. Review.
-
Best practice guide for the treatment of nightmare disorder in adults.J Clin Sleep Med. 2010 Aug 15;6(4):389-401. J Clin Sleep Med. 2010. PMID: 20726290 Free PMC article.
-
Clonidine Use for the Treatment of Nightmares in Posttraumatic Stress Disorder.Case Rep Psychiatry. 2022 Jan 17;2022:5251406. doi: 10.1155/2022/5251406. eCollection 2022. Case Rep Psychiatry. 2022. PMID: 35083090 Free PMC article.
-
Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD.Curr Psychiatry Rep. 2018 Jun 21;20(7):48. doi: 10.1007/s11920-018-0916-9. Curr Psychiatry Rep. 2018. PMID: 29931537 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical